Nepal | January 17, 2021

COVID-19 patients still have symptoms 6 months later; interferon may be helpful treatment after all

Reuters
Share Now:

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

Half a year later, COVID-19 patients still have symptoms

Most patients hospitalized with COVID-19 have at least one symptom six months after falling ill, according to findings from a study in Wuhan, China, where the novel coronavirus first emerged in late 2019. Doctors there tracked 1,733 patients who were diagnosed and hospitalized between January, 2020 and May. Six months later, 76% had at least one symptom including fatigue or muscle weakness (seen in 63%), sleep difficulties and anxiety or depression. Most of those who had been severely ill had ongoing lung problems and chest abnormalities that could indicate organ damage, while 13% of patients whose kidneys functioned normally in the hospital went on to develop kidney problems later, researchers reported on Friday in The Lancet. “We are only beginning to understand” some of the long-term effects of COVID-19, study coauthor Bin Cao from the China-Japan Friendship Hospital in Beijing said in a statement. “Our analysis indicates that most patients continue to live with at least some of the effects of the virus after leaving hospital,” highlighting the need for post-discharge care. (bit.ly/39hUKS2)

Interferon boosts proteins that deny entry to coronavirus

An experimental inhaled form of interferon being tested for treating hospitalized COVID-19 patients may not have a limitation researchers had feared. A potential problem with interferon is that it increases levels of a protein called ACE2, which the new coronavirus uses as a gateway into cells. In test tube experiments, researchers looked at cells that line the path from the nose into the lungs and discovered there are actually two forms of ACE2 – the well known one and a short form that lacks the entryway used by the virus. Interferon increases the short form of ACE2 but not the longer form, they found, which means it does not appear to boost entry points for the virus. “We were excited to discover a new form of ACE2,” Dr. Jane Lucas of the University of Southampton, who co-led the study reported on Monday in Nature Genetics, said in a statement. “We believe this may have important implications for managing COVID-19 infection.” An inhaled interferon from Synairgen Plc is being tested in late-stage trials. (go.nature.com/3oBO9Z0)

Saliva viral load improves prediction of COVID-19 severity

The amount of the new coronavirus in saliva might help guide doctors’ care of patients because it is a better predictor of disease course than viral load in swab samples obtained from the nose and the back of the throat, researchers said. They studied 26 mildly ill COVID-19 patients, 154 hospitalized patients – including 63 who became critically ill and 23 who eventually died – and 108 uninfected individuals. Saliva viral load, but not nasopharyngeal viral load, was linked with COVID-19 risk factors like age and gender, and with immune system responses. Saliva viral load was also superior to nasopharyngeal viral load at predicting critical illness and death, the researchers reported on Wednesday on medRxiv ahead of peer review. Saliva contains inhaled germs that are cleared from the lungs by the body’s protective mechanisms, coauthor Akiko Iwasaki of Yale University explained in a tweet on Sunday. The saliva viral load therefore reflects how well the virus is making copies of itself all the way through the respiratory tract, from the nose to the lungs, and not just in the nose and back of the throat, Iwasaki said. (bit.ly/3i1KpO9)

Open tmsnrt.rs/3a5EyDh in an external browser for a Reuters graphic on vaccines and treatments in development.


Follow The Himalayan Times on Twitter and Facebook

Recommended Stories:

More from The Himalayan Times:

In Pictures: Frontline COVID-19 health workers on duty

Kathmandu, January 16 A health worker is seen through a door inside the intensive care unit of COVID-19 isolation ward at Teku-based Sukraraj Tropical and Infectious Disease Hospital (STIDH), in Kathmandu, on Saturday. The ward currently has 11 COVID-19 patients under treatment. Dr Anup Bas Read More...

India starts world's largest COVID-19 vaccination drive

NEW DELHI: India started inoculating health workers Saturday in what is likely the world's largest COVID-19 vaccination campaign, joining the ranks of wealthier nations where the effort is already well underway. India is home to the world’s largest vaccine makers and has one of the biggest Read More...

Australia frustrated as rain dampens Gabba decider

A heavy downpour frustrated Australia on day two of the fourth test decider in Brisbane on Saturday, with play abandoned after tea and India spared from resuming on 62 for two in reply to the home side's first innings 369. India number three Cheteshwar Pujara was eight not out, with stand-i Read More...

India's prohibition on import of palm oil affects Nepali industries

BIRGUNJ: Most of the vegetable oil and ghee industries in Parsa and Bara districts have been affected after India imposed a ban on import of palm oil. It is estimated that 90 percent of these industries are adversely affected due to restriction on import decreed by India. Large investments of ind Read More...

Nepal COVID-19 Update: 240 new cases, 477 recoveries and six fatalities

KATHMANDU: Nepal’s Health Ministry shared the latest updates on coronavirus contagion from across the country. READ MORE: 131 new Covid-19 cases recorded today in Kathmandu valley Till date, 2,008,944 tests through Polymerase Chain Reaction (PCR) method have been carried out wherein 3,819 t Read More...

Prince climbs to third place in junior badminton world ranking

KATHMANDU: Nepal's young shuttler Prince Dahal has taken a big leap in the junior badminton world ranking. Dahal has climbed to the third place in the ranking published on Friday by the Badminton World Federation (BWF). He was in the seventh place in the previous ranking. Danish Mads Juel Moller Read More...

Uganda says president wins 6th term as vote-rigging alleged

KAMPALA: Uganda’s electoral commission says longtime President Yoweri Museveni has won a sixth term while top opposition challenger Bobi Wine alleges rigging and officials struggle to explain how polling results were compiled amid an internet blackout. In a generational clash widely watched Read More...

Renowned Spanish alpinist dies while descending Mt K2

KATHMANDU: A renowned Spanish climber died while descending from Camp I on Mt K2, expedition organiser said. Sergio Mingote Moreno died when he suddenly fell down to Advance Base Camp while descending from C1 to Base Camp, Chhang Dawa Sherpa, Expedition Director at Seven Summit Treks shared from Read More...